2 results
Approved WMOCompleted
To demonstrate that ofatumumab is superior to teriflunomide in reducing the frequency of confirmed relapses as evaluated by the annualized relapse rate (ARR) in patients with relapsing MS
Approved WMORecruiting
The primary objective is to evaluate the difference in 68Ga-exendin tracer accumulation in the pancreas of women with and without a history of GDM by quantitative analysis of PET images.